Substantial risk affects the stage-dependent outcomes of cisplatin-based adjuvant chemotherapy for completely resected non-small cell lung cancer.
about
Substantial risk affects the stage-dependent outcomes of cisplatin-based adjuvant chemotherapy for completely resected non-small cell lung cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Substantial risk affects the s ...... ed non-small cell lung cancer.
@en
Substantial risk affects the s ...... ed non-small cell lung cancer.
@nl
type
label
Substantial risk affects the s ...... ed non-small cell lung cancer.
@en
Substantial risk affects the s ...... ed non-small cell lung cancer.
@nl
prefLabel
Substantial risk affects the s ...... ed non-small cell lung cancer.
@en
Substantial risk affects the s ...... ed non-small cell lung cancer.
@nl
P2860
P1433
P1476
Substantial risk affects the s ...... ed non-small cell lung cancer.
@en
P2093
Ichiro Yoshino
P2860
P304
P356
10.1007/S00595-013-0509-5
P577
2013-02-11T00:00:00Z